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Abstract 
 
All muscle cells of the trunk and limbs are derived from the delamination of myogenic precursor 
cells (MPCs) from the dermomyotome of somites. Myogenic differentiation is then activated and 
orchestrated by myogenic regulatory factors. In the trunk, myogenesis begins with the formation 
of the myotome, a segmented muscle which progressively differentiates, reorganizes and 
translocates to form the definitive adult skeletal muscles. Nevertheless, external factors such as 
the extracellular matrix (ECM) are also important in myogenesis. Previous studies have proved 
that ECM plays important functions in primary myogenesis. It is thought that the fibronectin 
matrix may help muscle cell reorganization through its integrin receptors, in particular through 
α4, α5 and αv subunits. Here we mapped the 3D distribution of the fibronectin matrix in embryos 
throughout myotome development until its final reorganization. We also described 
thedistribution pattern of the αv integrin subunit. To assess the effect of fibronectin during the 
translocation of myocytes, we performed explant cultures, using the 70kDa fragment and the 
RGD peptide to inhibit fibronectin matrix assembly and cell-ECM interactions, respectively. Our 
data highlights a very dynamic behavior of fibronectin matrix in myogenesis. Fibronectin seems 
to be used as a guide by the MPCs entering the myotome from the central dermomyotome. αv 
subunit is present in all elongated myocytes  and enriched at their tips, showing that myocytes 
are able to attach to the thick fibronectin matrix at intersegmental borders, possibly serving as a 
tendon structure. Disruption of fibronectin assembly induces the collapse of the elongated 
muscle cells and disruption of the myogenic program. Similarly, inhibiting cell-ECM interactions 
does not perturb muscle morphology, but affects myogenic differentiation. Together, these 
observations highlight the importance of fibronectin during muscle development, including 
skeletal muscle morphogenesis.  
 
Key-words: fibronectin matrix; integrins; extracellular matrix; myogenesis; epaxial muscles; 
muscle morphogenesis; mouse embryo 
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Resumo 
 
A morfogénese dos músculos esqueléticos é um processo complexo que se inicia no 
embrião e se prolonga por toda a vida do indivíduo, envolvendo um conjunto de factores 
celulares autónomos e extrínsecos, bem como a diferenciação e maturação de vários tipos de 
precursores celulares. Os músculos esqueléticos dos vertebrados derivam da segmentação da 
mesoderme paraxial, alinhada lateralmente pelo tubo neural e notocorda, estendendo-se ao 
longo do eixo embrionário e medialmente localizada em relação à mesoderme intermédia e 
lateral. Este processo conhecido por miogénese, encontra-se bem estudado em ratinho 
iniciando-se com a formação do miótomo, ao fim de 8,5 dias de gestação. A formação 
progressiva e faseada do miótomo ocorre a partir da delaminação coordenada das células 
progenitoras miogénicas (CPMs), que simultaneamente expressam os factores de transcrição 
Pax3 e Pax7. Actuando a montante e em sincronia com estes factores, são activadas uma 
pleutropia de vias de sinalização em resposta a factores extrínsecos às células, provenientes 
dos tecidos adjacentes, que regulam o início do desenvolvimento miogénico. Assim, o 
crescimento do miótomo dá-se por vagas sucessivas e sincronizadas de CPMs provenientes 
do dermomiótomo. No miótomo, as CPMs podem diferenciar-se em mioblastos, através da 
activação de uma cascata de factores de regulação miogénica (FRMs) ou continuam a 
proliferar dentro das massas musculares, constituindo um nicho residente de células 
progenitoras, essencial para o crescimento e desenvolvimento dos músculos. Em ratinho a 
hierarquia de expressão dos vários FRMs encontra-se bem estudada. Myf5 e MyoD são os 
primeiros factores responsáveis pela especificação das células miogénicas e Mrf4 e miogenina 
controlam a manutenção das populações miogénicas, actuando na fase final do programa de 
especificação miogénico. Após acção dos FRMs, as células miogénicas começam a expressar 
proteínas estruturais musculares, como a desmina e miosina. Nesta fase, no miótomo, os 
mioblastos diferenciam-se em miócitos que se extendem paralelamente ao longo de toda a 
porção do miótomo até às fronteiras que delimitam o segmento. Estes continuam a diferenciar-
se, fundindo-se entre si atingindo sucessivamente a maturação, originando as massas 
musculares multinucleadas. A partir de um determinado estádio de E11.5/E12.5, as massas 
musculares epaxiais sofrem uma reorganização estrutural, alterando a sua orientação em 
relação ao eixoembrionário, mudando para os seus destinos finais de diferenciação. Este 
processo, designado por translocação muscular define a natureza transitória do miótomo, que 
acaba por desaparecer, formando os precursores das massas musculares adultas. Assim, a 
sequência de todo o programa miogénico pode ser definida como uma entidade complexa 
dependente da regulação e activação de factores intracelulares. Todavia, tal entidade também 
se baseia em processos de comunicação intercelular e interacções entre as células e o meio 
ambiente, onde se sabe que a matriz extracelular (MEC) representa um papel importante no 
desenvolvimento. Tal importância deve-se à grande versatilidade funcional da matriz, podendo 
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actuar como suporte físico-mecânico para as células ou reter sinais bioquímicos. A MEC é 
constituída por uma rede dinâmica e variada de macromoléculas, maioritariamente definida por 
glicoproteínas, proteoglicanos e colagénios. A fibronectina é uma das glicoproteínas mais 
comuns da matriz intersticial. A sua montagem é controlada pelas próprias células que 
secretam dímeros de fibronectina, que se ligam às superfícies celulares dessas células ou 
outras adjacentes através de receptores membranares específicos, designados por integrinas, 
unindo-se ente si, formando uma rede fibrilar complexa e compacta de fibronectina. Estudos 
anteriores realçam a importância da fibronectina na somitogénese dos vertebrados, assim 
como na diferenciação miogénica de linhas celulares in vitro. As integrinas são heterodímeros 
transmembranares, constituídos pela combinação múltipla de uma subunidade   α e outra β, 
sendo um dos principais elos de ligação entre as células e a MEC, através do motivo de ligação 
RGD. A combinação de cada subunidade perfaz um total de 24 integrinas funcionais com 
diferente especificidade. As integrinas α4β1, α5β1 e as de subunidade  αv, destacam-se por 
serem receptores da fibronectina e por se saber que são expressas durante a miogénese. 
Pretendemos, determinar de que modo a matriz e as suas interacções com as células 
influenciam o desenvolvimento miogénico, afectando a diferenciação, migração e o 
comportamento das células miogénicas. Numa primeira fase, tentámos entender a organização 
da fibronectina durante o desenvolvimento muscular, desde a formação do miótomo até à fase 
de translocação, através de experiências de imunofluorescência in toto em embriões e 
reconstruções 3D. Em estádios precoces, a fibronectina surge em abundância a delimitar as 
fronteiras intersomíticas, assim como todos os sómitos. Mais tarde notámos que pequenos 
feixes de fibronectina se propagam para o interior do miótomo, adquirindo a mesma orientação 
dos miótcitos e crescendo em complexidade à medida que as massas musculares se 
desenvolvem. Em estádios miogénicos tardios observámos que a fibronectina ocupa totalmente 
o espaço deixado pelo dermomiótomo, após a dissociação deste e que continua presente à 
volta das massas musculares. Precedentemente à dissociação do dermomiótomo, notámos a 
formação de pequenos feixes de fibronectina na parte lateral do miótomo, isto é, entre o 
dermomiótomo e o miótomo, atentando uma possível interacção entre as CPMs do 
dermomiótomo e a fibronectina. Para averiguar esta questão, realizámos experiências de 
imunofluorescência, em cortes de embriões, onde observamos a presença de feixes fibrilares a 
envolver as CPMs em translocação. Além dessas experiências, também recorremos à técnica 
de imunofluorescência para detectar a integrina  αv. Verificamos que, durante todas as fases 
em estudo está presente nos miócitos alongados, sendo especialmente enriquecida nas pontas 
dos mesmos, possivelmente promovendo o seu ancoramento à matriz de fibronectina. Em 
conjunto, os dados apontam para a possibilidade de um papel altamente dinâmico da 
fibronectina na morfogénese do músculo epaxial, tal como permitir a entrada das CPMs no 
miótomo, conferindo, mais tarde, suporte as células miogénicas para promover a sua 
diferenciação, alinhamento, maturação reorganização e eventual migração.  
Numa fase posterior, decidimos averiguar a influência que a MEC tem no comportamento das 
células durante a translocação do miótomo. Mais concretamente pretendemos caracterizar a 
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forma como a MEC, em particular como a ligação à fibronectina condiciona o desenrolar da 
miogénese. Para tal, realizámos culturas de explantes onde os mesmos foram sujeitos à acção 
de um fragmento amino terminal de fibronectina de 70kDa e um péptido com o motivo RGD, 
que respectivamente, bloqueiam a fibrilogénese da fibronectina e as ligações às integrinas que 
contêm este domínio de ligação à fibronectina, onde se seguiu a imunofluorescência in toto dos 
referidos explantes e reconstruções 3D. Notoriamente, obtivemos um efeito significativo no 
fenótipo das massas musculares, uma vez que estas se apresentavam colapsadas e os 
miócitos encurtados, sugerindo uma interrupção drástica no desenvolvimento das mesmas. 
Além disso, nestes explantes também se destacou a ausência da matriz de tenascina e de 
células miogenina-positivas, salientando a falta de suporte estrutural das células miogénicas e 
a inibição do respectivo programa de diferenciação. Quando incubados com o péptido RGD, os 
explantes apresentavam uma morfologia muscular normal, com presença de uma matriz de 
tenascina. Contudo, não identificamos quaisquer células positivas para miogenina, de entre os 
explantes analisados, sugerindo que a inibição da ligação à matriz via RGD não afecta 
significativamente o desenvolvimento dos músculos esquéleticos mas é suficiente para induzir 
uma interrupção no programa de diferenciação miogénico. 
 
Neste trabalho evidenciamos a existência de relações directas entre as células miogénicas com 
a matriz de fibronectina envolvente, essenciais ao seu próprio desenvolvimento, atentando para 
as funções de suporte estrutural que a esta desempenha. Mais ainda, revelamos que a matriz 
de fibronectina é essencial para a morfogénese dos músculos esqueléticos.  
 
Palavras-chave: fibronectina; integrinas; matriz extracelular; miogénese; músculos epaxiais; 
morfogénese muscular; embrião de ratinho 
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Introduction 
 
Somitogenesis: Segmenting the musculoskeletal system in 
vertebrates 
 
 Somite formation 
Muscle morphogenesis is a complex process that can extend throughout adulthood. 
Since muscles regulate several important biological functions, their study is important to 
understand the molecular and cellular networks that are behind their development. Among the 
different muscle types that constitute the vertebrates, skeletal muscles are the most abundant 
(Biressi et al., 2007). Vertebrate skeletal muscle formation, also known as myogenesis, is a 
highly regulated process. It directly depends on a plethora of autonomous and extrinsic signals, 
differentiation and maturation of different types of uncommitted multipotent cells and also 
involves extensive extracellular matrix (ECM) remodeling (Bryson-Richardson and Curie, 2008; 
Cossu et al., 2000; Czirók et al., 2004; Deries et al., 2011; Linker et al., 2003; Müstenberg and 
Lassar, 1995; Thorsteinsdóttir et al., 2011).  
The myogenic commitment program is 
activated in paraxial mesoderm and is regulated by 
.neighboring tissues such as the ectoderm, neural 
tube and notochord. The paraxial mesoderm lies on 
each side of the neural tube and notochord, 
extending along the embryonic axis (Kalcheim and 
Ben-Yair, 2005; Stockdale et al., 2000). The non-
segmented, caudal part of the paraxial mesoderm 
(presomitic mesoderm; PSM) undergoes a 
mesenchyme to epithelium transition, at its rostral 
end leading to the formation of a pair of somites 
(figure 1). Each somite is surrounded by a 
fibronectin matrix and is connected with the ECM, 
which stabilizes its epithelial morphology (Rifes et 
al., 2007; Martins et al., 2009; Christ et al., 2007). 
Somites give rise to a variety of structures such as 
the dermis, all muscles of the body and a few of the 
head, the vertebral column, ribs, some tendons and 
ligaments and some blood vessels (Baker et al., 
Figure 1: Caudal differentiated somites 
(asterisks) and somite boundaries 
(arrows) in a E9.5 mouse embryo. 
Abbreviations: psm-presomitic 
mesoderm; tb-tailbud. Aulehla and 
Herrmann, 2004 
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2006; Bothe et al., 2007; Mc Grew and Pourquié, 1998).  
 
 
Somite maturation and differentiation: specification of myogenesis 
As development proceeds, the ventral part of the somites de-epithelializes and forms 
the sclerotome and the dorsal part is now called the dermomyotome (Munsterberg and Lassar, 
1995; Dockter and Ordahl, 2000). 
The sclerotome is 
the precursor of vertebrae 
and ribs. The epithelial 
dermomyotome possesses 
four contiguous lips and is 
delimited by a basement 
membrane enriched in 
laminin (Tosney et al., 
2004; Bajanca et al., 2004; 
Kalcheim and Ben-Yair, 
2005). The 
dermomyotome will 
generate another somitic 
compartment, called the 
myotome, which is the first 
skeletal muscle that forms in vertebrates (figure 2).  
Dermomyotome cells express Pax3 and Pax7 and can give rise to several different 
mesodermal cell lineages such as all the myogenic cells of limbs and body, dorsal dermis, 
smooth muscle, endothelial cells and brown fat precursors (Buckingham, 2006; Christ et al., 
2007; Kalcheim and Ben-Yair, 2005; Relaix et al, 2003; Relaix et al., 2005). Pax3/Pax7 
expressing cells were identified as myogenic progenitor cells (MPCs) of all muscles of the body 
(Relaix et al., 2005, Kassar-Duchossoy et al., 2005, Gros et al., 2005, Kalcheim and Ben Yair, 
2005). MPCs of axial muscles migrate in distinct waves from the different dermomyotome 
domains and invade the area of the myotome (figure 3). 
The ability of dermomyotome to generate a large amount of precursor lineages depends 
on a balance between processes which promote the proliferative (uncommitted) versus the 
myogenic differentiated state (Buckingham, 2006; Buckingham and Vincent, 2009; Venters and 
Ordahl, 2005). Therefore, these cells can have two specific fates: either they become committed 
to skeletal muscle program and activate the myogenic regulatory factors (MRFs), differentiate 
into myocytes (Kalcheim and Ben Yair, 2005; Kassar-Duchassoy et al., 2005; Relaix et al., 
2005; Gros et al., 2005) or they continue to proliferate within the muscle mass during prenatal 
and adult development as a  pool of muscle progenitors (Kassar-Duchassoy et al., 2005; Relaix 
et al., 2005; Relaix et al., 2006). 
Figura 2: Scanning electron micrographs of transverse 
sections in a chick embryo. A - An epithelial somite. B - A 
compartimentalized mature somite. Note that the myotome is 
positioned between the dermomyotome and the sclerotome. 
Abbreviations: NT- neural tube; DM- dermomyotome; M-myotome; 
SCL- sclerotome. Adapted from Christ et al., 2007. 
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Myotome compartmentalization: determination and regulation of 
myogenesis  
Myotome formation has been intensely studied (Denetclaw and Ordahl, 2000; 
Denetclaw et al., 2001; Gros et al., 2004; Kahane et al., 2001; Venters et al., 1999) starting 
forming at about E8.5-
E8.75 in the mouse 
(Biressi et al., 2007; 
Hadchouel et al., 2000; 
Venters et al., 1999¸). 
Delamination of 
dermomyotomal cells 
starts in its medial region 
to form the epaxial 
myotome, from which all 
the deep back muscles 
arise (Venters et al., 
1999; Gros et al., 2004; 
Kalcheim and Ben-Yair, 
2005, Venters and 
Ordahl, 2002). A 
myotomal basement 
membrane, which 
separates the myotome 
from the sclerotome cells is then formed (Duband et al., 1987; Tosney et al., 1994, Bajanca et 
al., 2006). The MPCs that enter the myotome become myoblasts which express the myogenic 
regulatory factors (see below) and then differentiate into mononucleated, postmitotic myocytes 
which stretch bidirectionally parallel to the axis of the embryo until they reach the rostral and 
caudal somitic borders (Denetclaw and Ordahl, 2000; Gros et al., 2004; Hollway and Currie, 
2005). Later on, MPCs enter the myotome from all four dermomyotome lips contributing to the 
growth of the epaxial myotome in both length and width. The hypaxial myotome population 
arises from the translocation of MPCs from the lateral dermomyotome and contributes to 
abdominal and intercostal muscle formation (Gros et al., 2004; Sporle, 2001). Later on, at 
around E10.5 in mice, cells from the central part of the dermomyotome expressing Pax3 and 
Pax7 enter the myotome, forming a new pool of proliferating myogenic precursors, contributing 
Figure 3: Most recent model for myotome formation in chick  A- 
Myotome is formed by subsequent  waves of myogenic precursor 
cells,  first from the dorsomedial lip of the dermomyotome (red), then 
from the caudal and rostral borders (green) and finally from the 
ventro-lateral lip (blue) B- Different myogenic cellular populations 
within the myotome domain.  Abreviations: DML- dorsomedial lip; 
VLL- Ventro-lateral lip; NT- Neural tube; No-Notochord. Gros et al., 
2004.  
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to the growth of the myotome (Ben-Yair and Kalcheim, 2005 ; Gros et al, 2005 ; Kassar-
Duchossoy et al, 2005; Relaix et al 2005).  
Despite sharing the same somitic origin, trunk and limb muscles are formed by different 
regulatory mechanisms. Limb muscle masses are formed by the delamination and migration of 
MPCs expressing Pax3 and Pax7, from the hypaxial and central regions of the dermomyotome, 
respectively. These cells migrate to the limb bud where they form the limb muscle masses 
(Buckingham et al., 2003). Finally, head muscles are formed from the mesodermal core of the 
branchial arches and from prechordal mesoderm (Buckingham and Vincent, 2009; Noden and 
Trainor, 2005). Thus, during vertebrate morphogenesis we can find different muscle patterning 
pathways that underlies the myogenic program, depending on the axial level of the embryo.  
At later stages, the dermomyotome progressively dissociates. This dissociation starts in 
the dermomyotome central region at E10.5 in the mouse and at HH18 in the avian embryos and 
is marked by an increase of asymmetric cell divisions (Buckingham, 2006; Kalcheim and Ben-
Yair, 2005; Thorsteinsdóttir et al., 2011). Then, it spreads towards the epaxial and hypaxial lips 
that remain epithelial for a time before they get disintegrated (Venters and Ordahl, 2002).  
 
 
 The myogenic regulatory factors 
Myogenic regulatory factors (MRFs) are transcription factors which activate the skeletal 
muscle differentiation program. In vertebrates, four different MRFs: Myf5, MyoD, Mrf4 and 
myogenin, play a role in this process (Pownall et al., 2002; Buckingham et al., 2003).  
Myf5 and MyoD were identified as being the major regulators of muscle specification in 
vertebrates (Pownall et al., 2002). Mrf4 acts in the maintenance of myogenic cell populations 
being considered a muscle differentiation regulator (Kassar-Duchossoy et al., 2004). Myogenin 
modulates the action of several genes, especially the ones that are involved in fiber 
differentiation and regeneration, being used as a marker to detect differentiating skeletal muscle 
cells (Pownall et al., 2002). Myogenin acts to control myoblast differentiation, inducing the 
expression of the terminal skeletal muscle phenotype (Berges and Tapscott, 2005; Hinits et al., 
2009).  
The differentiation program activity will then induce the expression of muscle-specific 
structural proteins, such as desmin and myosin, in the myotome.  
 
 
 Myotome translocation 
In mammals and birds, the myotome is a transient structure that gradually transforms 
into new complex muscle masses. This constitutes a necessary event for muscle adaptation to 
terrestrial life (Deries et al., 2008).  In the mouse it occurs at E11.5, at the time when the 
myotomal myocytes start to fuse with each other and become multinucleated (Venters et al., 
1999). Gradually, the segmented structure of the myotome disappears and the complex axial 
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muscle masses form. This transformation of muscle fibers leads to a displacement of the 
myotomal cells, supporting the formation of epaxial muscles (Deries et al., 2010). The same 
occurs hypaxially to form the pre-vertebral, intercostal and abdominal muscles (Evans et al., 
2006).  
Remarkably, this transition 
occurs rapidly during 
embryogenesis and is poorly 
understood. Epaxial morphogenesis 
involves extensive movements of 
differentiated cells were the 
multinucleated myocytes elongate 
and change their orientation. The 
most dorsal-ones form a tilt at the 
rostral tip. From E12.5 
developmental stage onwards, the 
myotomal shape changes 
progressively to a more complex 
organization to form the axial 
muscle masses, while the myocytes become multinucleated (Deries et al., 2010; 
Thorsteinsdóttir et al., 2011). Thus, the epaxial myotome domain is gradually replaced by the 
adult deep back muscles, which can be divided in three main muscle groups: the tranverso 
spinalis, longissimus and iliocostalis muscles (figure 4) (Deries et al., 2010). All these muscles 
attach to the vertebrae and have an extensor function (Deries et al., 2010).  
However, it is also known that muscle translocation is not an epaxial musculature-
specific event. Extra-ocular muscles are formed by a massive migration of myogenic cells from 
the neural crest-mesoderm interface, which in turn, folds and reaches a periocular 
microenvironment, achieving their extra-ocular terminal promordia (Noden and Francis-West, 
2006). Moreover, it was recently discovered, in the mouse, that perineal muscles arise through 
movements of differentiated cells (Valasek et al., 2005). 
This abrupt transition of the embryonic segmented myotome into a complex muscular 
adult morphology may be influenced by the surrounding connective tissue or extracellular matrix 
(ECM). ECM has a tight spatio-temporal synchrony with musculoskeletal morphogenesis (Evans 
et al., 2006). Despite of this close relationship, until nowadays, the role of the ECM upon the 
skeletal muscle development remains unclear. Thus, the study of cell-ECM interactions during 
myogenic development is important to unveil if the ECM directly influences the final destination 
of differentiated cells by leaving footprint-like clues during the translocation phase. 
Understanding how muscles are formed it is important to develop therapies to treat muscular 
diseases. 
 
 
 Figure 4: Early epaxial muscle masses arising from the 
translocation of the segmented myotomal muscle masses. 
Abbreviations: TS- transverso spinalis; LG- longissimus; IC- 
Iliocostalis. Deries et al., 2011.  
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The extracellular matrix 
All cells of multicellular organisms are surrounded by and interact with an ECM 
throughout all life stages. The ECM is a complex and dynamic network composed of a large 
variety of macromolecules: the protein-rich molecules, which include collagens, laminins, 
tenascins and fibronectin, and the polysaccharide-rich family where glycosaminoglycans and 
proteoglycans are included (Frantz et al., 2010; Rozario and DeSimone., 2010; Thorsteinsdóttir 
et al., 2011). The interstitial ECM fills the spaces between tissues and is the matrix of 
connective tissue, while pericellular ECMs, such as basement membranes, are in close contact 
with cells (Goody and Henry, 2010; Frantz et al., 2010; Rozario and DeSimone., 2010; 
Thorsteinsdóttir et al., 2011). ECM molecules are produced by cells and are assembled into 
highly organised tridimensional (3D) matrices. ECMs have a wide range of different functions 
depending on ECM structure and composition. The ECM acts as a scaffold, providing an 
adhesive substrate, defining physical and mechanical proprieties to cells and can also have the 
ability to sequester and store several signaling molecules such as growth factors (Frantz et al., 
2010; Rozario and DeSimone., 2010). 
 
 
Fibronectin 
Fibronectin (FN) is a 
glycoprotein, containing binding sites 
for cell surface receptors and ECM 
molecules, including FN itself to allow 
FN matrix assembly (Mao and 
Schwarzbauer, 2005). FN matrix 
assembly is a cell-dependent process, 
in which cells secrete the FN dimer in a 
compact form. These dimers are 
engaged by integrin receptors on the 
cell surface, where they are unfolded, 
exposing fibronectin-fibronectin binding 
sites in the N-terminal assembly 
domain. Fibronectin molecules bind to 
each other through these assembly 
domains and progressively give rise to 
a stable fibrillar FN network (figure 5). 
FN is expressed early during vertebrate development (Wartiowaara et al., 1979; Perkinson and 
Norton, 1997; Trinh et al., 2004; Zhou et al., 2010). In chick embryo, it is produced by the 
ectoderm (Rifes et al., 2007) and surrounds the rostral PSM and the early formed somites 
(Duband et al., 1987; Ostrovsky et al., 1988).  
Figure 5: Fibronectin fibril assembly steps. First, FN 
soluble dimers binds to specific integrins (A) and 
other receptors (pink bars in B). Finally, FN-FN 
interactions form the FN fibrillar matrix (C). Blue 
molecule indicate the RGD motif. Mao and 
Schwarzbauer, 2005. 
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FN-null mouse embryos exhibit severe mesodermal and vascular defects, lack of 
somites, and a shortened antero-posterior axis, resulting in developmental arrest and death 
(George et al., 1993; Georges-Labouesse et al., 1996).  The role of ECM in myogenic tissues 
has received significant attention, due to the recognition of several congenital muscle 
dystrophies (Ringelmann et al., 1999). However, FN pattern during skeletal muscle 
morphogenesis and how it influences the behavior of muscular cells is still to be studied.  
 
 
 
ECM receptors 
All cells interact with the ECM through several types of surface receptors. Among these 
receptors, the integrins are the best studied (ffrench-Constant and Colognato, 2004; Hynes, 
2002; Streuli, 2009; Barczyk et al., 2010). 
Integrins are heterodimeric glycoproteins 
receptors composing by an α chain 
associated non-covalently to a β chain, 
forming an extracellular head, a 
transmembrane and a cytoplasmatic domain.  
The combination of these subunits defines 
the integrin specificity. In mammals, 18 α and 
8 β subunits have been described forming a 
total of 24 different integrins (figure 6).   
Integrins can exhibit different 
conformational states. The balance and 
combination between the nature of the ECM 
ligands and the intracellular proteins that are 
associated with the integrin cytoplasmatic 
domain regulates integrin activation and state, in a given tissue. Once integrins are linked to 
cytoskeleton, the integrin-mediated assembly triggers a large variety of downstream signaling 
pathways and transductions events (ffrench-Constant and Colognato, 2004; Hynes, 2002). 
Therefore, integrin based-adhesions act as an extracellular environment sensitive tool and 
provide a dynamic feedback to the cells (Barczyk et al., 2010; Danen and Sonnenberg, 2003). 
Thus, integrin activity is essential in the majority of biological process, where cell behavior and 
cell-fate determination are constantly regulated (e.g. gene expression, polarity, proliferation, 
mitosis, apoptosis, motility, migration, differentiation and cell shape), which modulates tissue 
development, function and disease. 
 
 
 
 
Figure 6:  Integrins heterodimers family in 
vertebrates. Barczyk et al., 2010. 
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Integrins in myogenesis 
ECM-integrin interactions play an important role in muscle development 
(Thorsteinsdóttir et al., 2011). Previous studies have described the expression of several 
integrin subunits (receptors to laminin, fibronectin and tenascin) during skeletal muscle 
development (Bajanca and Thorsteinsdóttir, 2002; Bajanca et al., 2004, Cachaço et al 2005; 
Fässler et al 1996; Hirsch et al 1994). Here, we will only focus on the integrins that specifically 
attach to fibronectin and which are known to be expressed during myotome development. Eight 
integrins (α4β1, α5β1, α8β1, αvβ1, αvβ3, αvβ6, αvβ8 and αIIbβ3) bind to FN (table 1). Until 
date, only the α4β1, α5β1 and αv-containin integrins are known to be present during epaxial 
muscle morphogenesis (Thorsteinsdóttir et al., 2011). 
The α5β1 integrin is believed to be a key receptor of FN. It is involved in a large range 
of cellular processes being highly expressed during embryogenesis (Taverna et al., 1998).  
mRNA for the α5 integrin subunit (Itga5) starts to be expressed in the PSM, where FN matrix is 
assembled (Bajanca et al., 2004; Rifes et al., 2007). At E10.5, Itga5 is expressed by the 
myotomal myocytes and by MPCs migrating to the limbs (Bajanca and Thorsteinsdóttir, 2002; 
Bajanca et al., 2004). At E12.5, Itga5 is expressed within the trunk and forelimb muscles 
masses (Cachaço et al. 2005).  Mouse Itga5-null embryos die before myogenesis (Goh et al., 
1997; Yang et al., 1993), but in chimeric embryos, several alterations in skeletal muscle 
formation are observed, with a delay in muscle development and an increase of muscular 
dystrophy (Taverna et al., 1998).  
The α4β1 integrin binds both fibronectin and VCAM-1 (Rosen et al., 1992). In the 
mouse, α4 is present in the dermomyotome at E9.5 and is later upregulated in the myotome 
(Bajanca et al., 2004). At E12.5 it is detected in trunk and between E12.5-E14.5, it is also 
present in the forelimb muscle masses, having a wider expression pattern than α5 subunit 
(Cachaço et al., 2005). In the mouse, absence of α4 subunit (Itga4) leads to cardio-vascular 
defects and death between E11.0 and E14.0 (Yang et al., 1995), and chimeric α4-null embryos 
and cultured α4-deficient cells exhibit no significant morphological skeletal muscle defects 
(Yang et al., 1996).  
αv subunit-containing integrins can bind fibronectin, tenascin, vitronectin, among others 
(table 1). In skeletal muscle, αv is first detected in E10.5 in myotomes and at E12.5 it is present 
in limb and trunk muscle masses, being enriched in myotubes extremities  (Hirsch et al., 1994)., 
Ablation of αv leads to a neonatally death caused by severe intracerebral and gastrointestinal 
hemorrhages with no muscle defects reported (Bader et al., 1998; Thorsteinsdóttir et al., 2011).  
Despite these studies, many gaps remain in our knowledge to understand how cell-
ECM interactions are involved in skeletal muscle morphogenesis. 
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Table 1: Integrins and their ECM ligands. Abbreviations: Col-Collagen; Fn-Fibronectin, Ln-
Laminin; Nn-Nephronectin, Opn-Osteopontin; Tn-Tenascin; Vn-Vitonectin. Adapted from 
Thorsteinsdóttir et al., 2011. 
Integrin α4β1 α5β1 α8β1 αvβ1 αvβ3 αvβ6 αvβ8 αIIbβ3 
 
ECM 
ligand 
 
Fn 
 
Fn 
 
Fn, Tn, 
Vn, Nn 
 
Fn, Vn, 
Opn 
Vn, Fn, 
Tn, Ln 
(α1 
chain), 
Opn 
 
Fn, Tn 
 
Vn, Col 
IV, Fn, 
Ln (α1 
chain)  
 
Fn, Vn 
 
 
 
 
 
Aims of this thesis 
 
We aimed to study the relationship between the fibronectin matrix and the myogenic 
cells during early axial myogenesis in mouse embryos. First, we analyzed the distribution 
pattern of fibronectin to understand the 3D organization of this matrix during the skeletal muscle 
morphogenesis. Then, we examined the spatial profile of the integrin αv subunit, a potential 
fibronectin receptor. Finally, we studied the effect of fibronectin matrix assembly inhibition and 
the interruption of cell-ECM interactions during the development of the epaxial muscle masses, 
through the analyses of their morphology and the expression of myogenic regulatory factors.  
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Materials and Methods 
 
Embryo collection 
Wild-type adult mice (Charles-River CD1; Harlan Interfauna Iberica, SA) were crossed and the 
day of the plug designated as E0.5. Pregnant females were sacrificed by cervical dislocation 
and the embryos were removed from the uterus in cold phosphate buffered saline (PBS;   annex 
I). Developmental ages of the collected embryos range between E9.5 and E12.5 (this project 
has the approval of Direcção Geral de Veterinária). 
 
 
Fluorescent immunohistochemistry 
 On cryosections 
Immunohistochemistry on sections was performed as in Bajanca et al., 2004. Embryos were 
fixed overnight (ON) at 4ºC, in 0.2% paraformaldehyde (PFA) in solution 1 (annex I). Then, they 
were washed in solution 1 and 2 both ON at 4ºC (annex I). After these incubations, the 
specimens were incubated in a gelatin and sucrose solution (solution 3; annex I) for 1 hour at 
37ºC and frozen immediately in isopentane chilled with dry ice. Embryos were stored at -80 ºC 
until use. 30µm thick sections were made in a Bright Clinicut cryostat and placed on SuperFrost 
Ultra Plus microscope slides (Menzel-Gläser). Sections were air dried during 1 hour before 
being washed 3x5min in PBS. The specimen were then blocked for 30 min in a blocking 
solution (1% bovine serum albumin (BSA; Sigma) in PBS) and incubated with primary 
antibodies (table 2) ON at 4ºC. The next day, samples were washed 3x10min in PBS, blocked 
for 30 min in the blocking solution and stained with secondary antibodies (with TO-PRO3, 
Invitrogen 1:500 and RNase 10µg/ml, Sigma) (table 2) for 2h at room temperature (RT). 
Sections were then washed 3x5min in a 4 strength PBS solution (4xPBS; higher salt 
concentration is more efficient to remove non-specific bindings). Stained sections were fixed for 
45min in 2% PFA in PBS and washed again 3x20 min in PBS. Samples were mounted in 
propyl-galate-PBS-glycerol (annex I), sealed with nail varnish and stored in the dark at 4ºC until 
viewed on the confocal microscope. All antibodies were diluted in the blocking solution. 
 
 
Whole mounts 
For whole mount embryo immunohistochemistry we used two different methods. The 
DMSO/Methanol method uses DMSO as the primary permeabilizing agent and is efficient to 
stain the ECM (Deries al., 2008). However, this method does not preserve membrane receptor. 
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In addition, this method requires that embryos be stored in DMSO/Methanol for 3 weeks before 
the immunostaining. In second method, the Triton method uses Triton-X100 as a permeabilizing 
agent and the embryos can be stained just after fixation (Venters et al., 1999). This protocol 
preserves membrane receptors and is much shorter to perform.  
 
DMSO/Methanol method 
Embryos were fixed in 2% PFA in PBS ON at 4ºC, washed 3x1h in PBS, 1h in a 0.1M 
glycine diluted in PBS to remove the aldehyde radicals of the PFA, which create fluorescent 
background and 1h again in PBS.  Specimens were then, progressively dehydrated in 
increasing methanol solutions, 15 min each one (20%, 50%, 80% and 100%, respectively), 
permeabilised with a solution of DMSO:methanol (1:4) for three weeks at 4ºC and stored in 
methanol 100% at -20ºC until use. After rehydration and several washes in PBS, samples were 
dissected as appropriate (table 3) and incubated with primary and secondary antibodies 
(including TO-PRO3 1:300 and RNase 10µg/ml, 1:100) in PBS containing 1% BSA (Sigma) and 
20% DMSO solution (annex I), ON at 4ºC. After each antibody application, embryos were 
extensively washed in 4xPBS for two days, where the 4xPBS was changed every 2h. After 
immunolabeling, embryos were dehydrated in methanol and stored at -20ºC until use or 
transparentized in methylsalicylate (Martins et al., 2009) and mounted in glass coverslips sealed 
with paraffin to analyze with confocal microscopy.  
 
Triton method 
Embryos were fixed in 0.2% PFA in PBS ON at 4ºC. Then they were dissected as 
appropriate (table 3) and washed 2x1h in PBS, permeabilized in a 0.2% ID solution (annex I) for 
4h and stained with primary antibodies diluted in 0.2% ID, at 4ºC for 3 days (table 2). Embryos 
were washed all day in 4xPBS (changed every 2h) with agitation at RT and left in the same 
solution ON at 4ºC. Secondary antibodies diluted in 0.2% ID were added (with TO-PRO3 1:300 
and RNase 10µg/ml, 1:100) and incubated for 2 days at 4ºC (table 2). One more time, embryos 
were washed all day. After the washing period, stained samples were fixed 2h in 2% PFA in 
PBS and a 0.1M glycine solution diluted in PBS was added for 1h. Samples were then washed 
in 4xPBS for the rest of the day. Finally, embryos were progressively dehydrated in methanol 
and mounted as described above. To visualize myogenic cells, we used either a cocktail of 
three mouse antibodies (anti-myogenin, anti-desmin and anti-MHC) or, particularly at later 
stages, only the anti-MHC antibody.  
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Explants cultures 
For culture experiments, embryos were collected, as described above, and immediately 
dissected as appropriate (table 3) in Dulbecco’s Modified Eagle Medium/F12 GlutaMax medium 
(DMEM/F12) (Invitrogen) supplemented with 10mM HEPES (Sigma; annex I), 1mM sodium 
pyruvate (Invitrogen), and 100U/ml penicillin and streptomycin antibiotics (Invitrogen). After 
dissection, embryos were divided into different experimental groups.  
In one set of experiments, the culture medium of experimental explants was 
supplemented with 100µg/ml of a 70kDa fibronectin fragment (Sigma), whereas control explants 
were incubated with 100 µg/ml of BSA (table 4). The 70kDa fibronectin fragment inhibits FN 
matrix assembly by competing with native FN for the FN-FN binding sites (McKeown-Longo and 
Mosher, 1985; Rifes et al., 2007).  
In another set of experiments, experimental explants were incubated in culture medium 
supplemented with 4.5 mM of RGD peptide (Sigma), whereas control explants were incubated 
in the same culture medium but with 4.5 mM of DGR peptide (Sigma; table 4). The RGD peptide 
acts by blocking the RGD recognition site on integrins which use this site to bind to their ECM 
ligand (figure 5), thus blocking cell-ECM binding through those integrins. All cultured embryos 
were positioned on 0.8µm polycarbonate Millipore filters (IsoporeTM) and incubated for 12h, at 
37 ºC with a 5% carbon dioxide humified atmosphere. 
After the time of the culture, explants were processed for whole mount 
immunohistochemistry (Triton method) and analysed by confocal microscopy (figure 7). 
 
 
 
 
Table 2: Antibody list  
 Antibody Reference Company Dilutions used 
(on sections; 
whole mounts or 
cultures) 
 
 
 
 
 
 
Primary 
 
 
Antibodies 
Anti-Desmin D3 D.S.H.B. 1:100; 1:50 
Light meromyosin MF20 asc D.S.H.B. - ; 1:50 
Anti-Human Fibronectin F-3648 Sigma 1:400; 1;100 
Anti-Tenascin LAT-2 A.Sonnenberg -; 1:50 
Anti-Myogenin F5D D.S.H.B. 1:100; 1:50 
Anti-α4 integrin PS/2 Serotec 1:50; 1:50 
Anti-Myosin Heavy Chain F59 D.S.H.B. 1:100; 1:50 
Anti-Pax7 Pax7 D.S.H.B. 1:100; 1:50 
Anti-Pax3 Pax3 D.S.H.B. 1:100; 1:50 
CD49d endotoxin low MCA1230EL Seretec 1:50; 1:50 
Anti-Myogenin SC-576 Santa Cruz -; 1:50 
Anti- αv integrin CD51 Enzo 1:500; 1:250 
 
Secondary 
 
Antibodies or 
Stains 
Alexa Anti-Mouse 568 A-11019 Mol. Probes 1:1000; 1:1000 
Alexa Anti-Rabbit 488 A-11070 Mol. Probes 1:1000; 1:1000 
Alexa Anti-Mouse 633 A21050 Mol. Probes 1:1000; 1:1000 
Alexa Anti-rabbit 568 A21069 Mol. Probes 1:1000; 1:1000 
Goat Anti-Rat 488 A11006 Mol. Probes 1:1000; 1:1000 
TO-PRO3 T3605 Mol. Probes 1:500; 1:300 
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Figure 7: Scheme of the explant cultures protocol (in the previous page)  After their collection the embryos 
were split into different groups. T0 embryos were immediately fixed. Tested explants (E11.5 and E12.0) were 
cultured for 6h or 12h and fixed. The experimental explants (incubated with 70kDa fragment, BSA, RGD or 
DGR) were incubated during 12h. All embryos or explants were stained by immunohistochemistry after fixation 
and each staining is indicated. The developmental stages of the explants after culture are also indicated. 
Embryo stage images were reproduced from 
http://www.emouseatlas.org/emap/ema/theiler_stages/StageDefinition/stagecriteria.html 
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Table 3: Description of methods for embryo dissection 
Developmental stage Embryo processing description 
 
E9.5 
Remove head and heart 
Small incision in the cranial edge of the neural tube 
 
 
E10.5-E12.5 
Remove head and internal organs 
Split down across the midline 
Remove limbs and neural tube 
 
 
 
 
Table 4: Inhibitory drugs used in explant cultures experiments 
Drug Company Catalog Use Concentration References Control 
70kDa 
fragment 
Sigma F0257 Inhibits FN 
fibrillogenesis  
100 µg/ml McKeown-
Longo and 
Mosher, 
1985; Rifes 
et al., 2007  
 
BSA  
RGD  
peptide 
Sigma G4391 Block FN α5 
and αv 
integrin   
binding 
 
4.5 mM 
Takahashi 
et al., 2007 
DGR 
peptide 
(ref. 
S3371) 
 
 
Image acquisition and 3D reconstruction 
Confocal stacks (embryo sections, whole mounts and explants) were acquired on a Leica SPE 
laser scanning confocal microscope with a 20x 0.7NA and a 40x ACS APO 1.15 oil-immersion 
lens. Whole mounts and cultured explants stacks were 3D reconstructed and analyzed using 
the Amira v5.3.3 software (Visage Inc.). One individual segment and its associated matrix were 
isolated by manual contouring of confocal sections (i.e. other cells and the matrix from 
surrounding tissues were “digitally erased”). Embryo cryosections stacks were treated and 
analysed on Image J v1.44p to produce Z-projections images. 
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Results 
 
Fibronectin dynamics along early skeletal muscle development    
To better understand the relationship between the surrounding interstitial ECM and the 
dermomyotomal and myotomal cells, we described the precise 3D distribution pattern of 
fibronectin, within and around the dermomyotome/myotome, during the beginning of the 
myogenic program until the translocation of the myotomal myocytes (E9.5-E12.5). Whole mount 
embryos were stained by immunofluorescence to visualize myogenic cells and the fibronectin 
matrix. Confocal images were rendered to obtain a 3D reconstruction of the fibronectin matrix 
with the myogenic cells (materials and methods). Figures 8-11 show isolated segments of each 
stage with myogenic cells in red, the whole fibronectin in white and transparentized to be able to 
see inside the segment and the fibronectin inside the segment (i.e. excluding dermomyotomal 
and intersegmental fibronectin matrix) in yellow. As the fibronectin staining inside the segment 
was weaker, we increased the exposure time to values above the average to allow its 
visualization. Moreover, cryosections were also immunolabelled with the same staining for each 
stage showing myogenic cells in red and fibronectin in green.  
 
 Fibronectin is enriched at intersegmental borders and runs along 
the medial side of the myotome 
At E9.5 hindlimb level, the somites are still epithelial with fibronectin surrounding them 
(Ostrovsky et al., 1988) and the dermomyotome is not yet morphologically distinguishable from 
the presumptive sclerotome. Myotome is only identified, with fully differentiated cells expressing 
MHC, at interlimb level (figure 8A-E). At this stage, a fibronectin matrix fills all the interstitial 
space on the lateral side of the dermomyotome, i.e. the space between the ectoderm and the 
dermomyotome (figure 8A, C, E, F, H and J). Fibronectin is highly abundant in the intersomitic 
borders, as well as around all somites, separating them from each other and surrounding 
tissues, at all levels (figure 8A, B, F, G, D, and white arrows in I). It is also possible to observe 
that epaxially, the fibronectin matrix is organized in small bundles on the medial side of the 
myotome and between the myocytes (figure 8B, D, G and green arrows in G and I). At forelimb 
level (figure 8F-J), when the dermomyotome and the myotome are more mature (note that the 
number of myocytes have increased) the fibronectin labeling forms small protrusions that starts 
to run along the myocytes into the myotome and on the lateral side of the myotome, between 
the dermomyotome and the myotome (Figure 8H and arrow in J).  
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 Figure 8: Fibronectin distribution in a E9.5 mouse embryo.   
Immunohistochemistry on whole mounts (A-D and F-I) and cryosections (E, J) of E9.5 embryos at interlimb (IL, A-E) and 
forelimb levels (FL, F-J) stained for fibronectin and myogenic cells. The whole mount were reconstructed in 3D, myogenic 
cells are in red, fibronectin in transparent white and the fibronectin inside the segment in yellow. On sections, myogenic 
cells are in red and fibronectin in green. The epaxial (Ep) side upwards and the hypaxial (Hyp) side downwards. In lateral 
views, rostral is to the left and to the right on medial views. Transversal (C and H) and sagittal slabs (D and I) were 
obtained from the 3D reconstructions. Fibronectin is very abundant through all stages in intersegmental borders, (white 
arrows in I) bundles run along myocytes on the medial side of the myotome (B and green arrows in G) and invading the 
myotome (green arrows in I). Some bundles of fibronectin are also seen between the myotome and the dermomyotome 
on the lateral side of the myotome. (arrow in J). NT- Neural tube; D-Dorsal; V-Ventral; M-Medial; L-Lateral. Scale bars: 
150µm on whole mount reconstructions and 100µm on sections.  
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Fibronectin matrix occupies the space between the dermomyotome and 
myotome and elongates into the muscle masses 
As myogenesis progresses, at E10.5, the number of myocytes increases and these 
myocytes elongate (figure 9). In fact the myotomal myocytes now span the whole segment and 
start to penetrate the ECM at the intersegmental borders (figure 9D, I and N).  As the segments 
mature, the fibronectin matrix becomes denser on the lateral side of the dermomyotome and on 
the medial side of the myotome (figure 9, compare hindlimb, A-E, interlimb F-J, and forelimb 
level, K-O). Bundles of fibronectin elongate form the intersegmental border into the segment 
and it seems that fibronectin matrix increases its involvement with the myocytes, as more and 
more fibrils penetrate into the muscle masses (figure 9, green arrows in A, D, G and K, F, white 
arrow in I). Interestingly, most of these bundles have the same orientation as the myotomal 
myocytes (figure 9A, B, F, G, K and L). The fibronectin matrix which occupies the space 
between the dermomyotome and the myotome has increased (figure 9C, E, H, J, M and O, 
white arrows) and it is interesting to notice that this augmentation coincides with the entry of 
muscle progenitor cells (MPCs) into the myotome, originating from the central part of the 
dermomyotome (Relaix et al 2005, Kassar-Duchossoy et al 2005). 
 
As the dermomyotome begins to dissociate, fibronectin invade the all 
the dermomyotal space and enshets the myotome 
At E11.5, fibronectin is strongly present around the myotome. The matrix is generally 
thicker and the fibronectin bundles are denser than at previous stages (figure 10). On whole 
mount reconstruction, it seems that fibronectin is present more dorsalaterally, in an epaxial to 
hypaxial gradient, both on the lateral and medial sides (figure 10A, B, F, G, K and L). However, 
this pattern was not observed in immunofluorescence experiments on sections (figure 10E, J 
and O). This differences registered may be due to a problem in the antibody penetration, since 
in whole-mount embryos the tissues are thicker than in sections. Fibronectin has also invaded 
the dermomyotomal space that has de-epithelialised (figure 10C, E, H, J, M and O, arrows) but 
the area occupied by the epithelial epaxial dermomyotome lip, remains free of fibronectin (figure 
10J, arrows). At forelimb level when this epaxial lip has de-epithelialised, fibronectin invades all 
tissues surrounding the myotome, including the forming dermis and the space left by the de-
epithelialisation of the dermomyotome and becomes tightly associated with the muscle cells 
around and within the myotome (figure 10C, arrows in E, H and M). The interstitial fibronectin 
matrix remains dense and continues to be present during the beginning of the transformation of 
the myotome.  
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 Figure 9: Fibronectin distribution in a E10.5 mouse embryo.  
Immunohistochemistry on whole mount (A-D, F-I and K-N) and cryosections (E, J, O) of E10.5 embryos at hindlimb 
level (HL, A-E), interlimb (IL, F-J) and forelimb levels (FL, K-P) stained for fibronectin and myogenic cells. The whole 
mount were reconstructed in 3D with myogenic cells in red, fibronectin in transparent white and the fibronectin inside 
the segment in yellow. On sections, myogenic cells are in red and fibronectin in green. The epaxial (Ep) side 
upwards and the hypaxial (Hyp) side downwards. In lateral views, rostral is to the left and to the right on medial 
views. Transversal (C, H and M) and sagittal slabs (D, I and N) were obtained from the 3D reconstructions. At E10.5 
myocytes elongate into the intersegmental fibronectin matrix (arrows in A, G and K). Fibronectin matrix occupies the 
space between the dermomyotome and myotome (arrows in C, E, H, J, M and O) and some fibrils elongate along the 
muscle masses (arrow in D and I). NT-Neural tube; D-Dorsal; V-Ventral; L-Lateral. Scale bars: 150µm on whole 
mount reconstructions and 100µm on sections.  
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Figure 10: Fibronectin distribution in a E11.5 mouse embryo. Immunohistochemistry on whole mount (A-D, 
F-I and K-N) and cryosections (E, J, O) of E11.5 embryos at hindlimb (HL, A-E), interlimb (IL, F-J) and forelimb 
levels (FL, K-P) stained for fibronectin and myogenic cells. The whole mounts were reconstructed in 3D with 
myogenic cells in red, fibronectin in transparent white and the fibronectin inside the segment in yellow. On 
sections, myogenic cells are in red and fibronectin in green. The epaxial (Ep) side is upwards and the hypaxial 
(Hyp) side downwards. In lateral views, rostral is to the left and to the right on medial views. Transversal (C, H 
and M) and sagittal slabs (D, I and N) were obtained from the 3D reconstructions. Fibronectin fibrils are thick and 
elongated within the muscle masses (A, B, F, G, K and L). At hindlimb and interlimb (A-J) the central part of the 
dermomyotome has de-epithelialised (arrow in J) and fibronectin has invaded the newly mesenchymal space (H 
and J). At forelimb level the whole dermomyotome is de-epithelialised and fibronectin seems to be present in 
every part of the tissue, even the muscle mass. (arrows in C, E, H, J, M and O). NT-Neural tube; D-Dorsal; V-
Ventral; M-Medial; L-Lateral. Scale bars: 150µm on whole mount reconstructions and 100µm on sections.  
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At later stages fibronectin continues to be present around and within 
the muscle masses  
At E12.5, myotomal myogenic cells are in the translocation phase to give rise to the 
adult epaxial muscle masses (introduction). Unfortunately, whole mount immunohistochemistry 
at this stage was unsuccessful, probably due to incomplete fibronectin antibody penetration 
(materials and methods). Therefore, immunohistochemistry on sections was the only efficient 
method to visualize the distribution pattern at this stage. A fibronectin matrix is present around 
and within the muscle masses at all levels (figures 11 arrows in D, H and L). The fibronectin 
matrix seems to be less fibrillar than at previous stages. However, it is difficult to assess the 
exact 3D shape of the matrix as we are only seeing stained cryosections. It is possible that the 
fibrils are smaller because they have less space within the more dense muscle masses (figure 
11, G and K).  
 
 
 
 
 
 
 
 
 
 
 Figure 11: Fibronectin distribution in a E12.5 embryo.  
Cryosections of E12.5 embryos were labeled by immunohistochemistry with antibodies 
against  MHC (B, F, J and red in D, H, L) and fibronectin (C, G, K and green in D, H, L) at 
hindlimb (B-D, HL), interlimb (F-H; IL) and forelimb (J-L) levels. The orientations of each 
section are indicated by a dashed line on the embryo images (A, E and I). Fibronectin is 
highly present around and within the muscle masses (arrows in D, H and L).  Images of the 
embryos were taken at http://mouseatlas.caltech.edu/gallery.html. D-Dorsal; V-Ventral; M-
Medial; L-Lateral. Scale bars: 100µm.  
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Cell- ECM interactions during myogenic morphogenesis 
To test the possible relationships between the fibronectin matrix and the MPCs entering 
the myotome from the central part of the dermomyotome, immunohistochemistry on 
cryosections was done using mouse embryos at stages from E9.5 to E11.5. Sections were 
labelled against fibronectin (figures 12B, F, K, O and S) and with an antibody combination 
against Pax3 and Pax7 to mark the MPCs (Relaix et al 2005; Kassar-Duchossoy et al. 2005; 
figures 12C, G, L, P and T).  
 A fibronectin matrix is in a position to aid MPC entry into the 
myotome 
Pax3 is expressed in the somite and then becomes restricted to the dorsal part of the 
somite, the dermomyotome. Subsequently, Pax7 is also expressed in the dermomyotome 
(Buckingham, 2006). At these early developmental stages (figure 12A-D), a fibronectin matrix is 
abundant all around the somites and in the intersegmental borders as seen on whole-mount 
embryos at the same stage (see above, figure 8A, D, F and I). At E9.5 forelimb level, the first 
MPCs delaminating from the hypaxial dermomyotome lip starting to migrate towards the limb 
bud, are also positive for Pax3 (Goulding et al., 1994; figure 12C). It is interesting to note that 
small patches of fibronectin surround these migrating MPCs (figure 12, arrow in D). Fibronectin 
matrix staining labels the ectoderm and all the interstitial space ventral to the dermomyotome 
(figure 12B). 
At E10.5, the first Pax3/ Pax7-positive cells start to leave the central part of the 
dermomyotome to enter the myotomal space. These cells are the pool of MPCs which will 
eventually contribute to the growth of the myotome and the axial muscles. (Relaix et al., 2005 
and Kassar-Duchossoy et al., 2005, figure 12, yellow arrows in G and L). Concomitantly, 
fibronectin bundles increase in number in the area between the dermomyotome and myotome 
(figure 12, yellow arrows in F and K, H and white arrow in M). A close-up view of an oblique 
section shows that cells that are entering the myotome are in close contact with these 
fibronectin fibrils (figure12, arrows in I). This relationship between the Pax3/Pax7-positive cells 
and the fibronectin is not seen at earlier stages when the cells are still in the dermomyotome 
(shown at E9.5 IL figures12B-D). At all levels E11.5, when the dermomyotome dissociates 
completely and release the MPCs on its medial side (Kalcheim and Ben-Yair 2005), the 
fibronectin matrix between the dermomyotome and the myotome becomes even thicker (figure 
12 yellow arrows in O and S, white arrows in Q and U) than at the previous stages (figure 12F-H 
and K-M). As seen on a longitudinal (figure 11O-Q) and on a transverse section (figure 12S-U), 
fibronectin fibrils spread from the intersegmental borders, through the myotome area and 
Pax3/Pax7-positive MPCs seem to be completely surrounded by the fibrils (figure 12 arrows in 
Q and U).  Together, these results suggest that the fibronectin matrix may help mediate the 
entry of Pax3/Pax7-positive cells into the myotome.  
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Figure12: Fibronectin matrix and MPCs relationship during myogenic development. 
Cryosections of  E9.5 (B-D), E10.5 (F-I and K-M) and E11.5 mouse embryos (O-Q and S-U) 
at different levels and orientation indicated by dashed lines  in A, E, J, N, R. Sections were 
immunostained for fibronectin (B, F, K, O and S; green in D, H, M, Q, and U) and Pax3 and 
Pax7 (C, G, L, F and T; red in D, H, M, Q, and U) at interlimb (IL, F-H, O-Q), and forelimb 
levels (FL, B-D, K-M, S-U). At early stages, the dermomyotome expresses Pax3 and Pax7 
and is surrounded by fibronectin on its lateral side (B and D). Fibronectin is abundant around 
the somites and in the intersegmental borders (B and D) and surrounds the first delaminating 
MPCs from the hypaxial dermomyotome (arrows in D).  At E10.5, Pax3 and Pax7 expressing 
cells start enter the myotomal space from the central part of the dermomyotome (arrows in G 
and L) and fibronectin matrix occupies the space between the dermomyotome and myotome 
(arrows in F, I, K and M) with thick fibrils which are in close contact with the Pax3/ Pax 7 
positive cells (arrows in H and M). At E11.5, a patchy line of fibronectin delimits the 
dermomyotomal from the myotomal space (O, Q, S and U). Fibronectin fibrils spread through 
the dermomyotome and myotome areas and surrounds the MPCs (arrows in O, Q, S and U). 
Embryo images were reproduced from http://mouseatlas.caltech.edu/gallery.html. NT-Neural 
tube; D-Dorsal; V-Ventral; M-Medial; L-Lateral. Scale bars: 100µm.  
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α4 and α5 integrins subunits immunofluorecence experiments 
reveal a lack of  immunoreactivity quality 
We were also interested in characterisng the distribution of the integrins that are known 
to specifically interact with fibronectin matrix. For that purpose we performed co-
immunolabelling experiments on sections for α4, α5 and αv integrins subunits on E9.5 to E12.5 
mouse embryos to determine whether any of these integrins are in a position to mediate 
interactions between the myogenic cells and fibronectin (see material and methods).  
Unfortunately, the batches of two different antibodies, against α4 integrin subunits (table 2) that 
we received did not give as good results as the batches used previously in the lab (Bajanca et 
al., 2004 and Cachaço et al., 2005) with the same protocol and embryo stages (compare figure 
13 arrows in A and B). The antibody that was used against the α5 integrin proved to cause 
unspecific staining, and the signal was present in all tissues (figure 13 C and E). Thus, we were 
unable to draw a detailed description of the distribution pattern of these two proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: α5 and α4 integrins antibodies have a lower quality of 
immunofluorescence. A and B: transverse sections at hindlimb level in a E10.5 
embryo (A) and in a caudal myotome at E11.5 (B) immunolabelled with the α4 integrin 
current batch (arrows in A), and one used earlier (arrows in B). Image B adapted from 
Cachaço et al., 2005. NT-Neural tube; D-Dorsal; V-Ventral; L-Lateral; M-Medial. C-E: 
Transverse section of E9.5 mouse embryos at interlimb level immunolabelled for α5 
(green) and DNA (TO-PRO3, blue). Images adapted from Raquel Vaz, Master Thesis, 
University of Lisbon, Portugal. Scale bars: 100µm.  
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αv integrin subunit is  enriched in the tips of epaxial myocytes 
We also analyzed the expression pattern of the αv integrin subunit at stages between 
E9.5 and E12.5 by immunohistochemistry on sections, stained with antibodies against myocytes 
(red) and αv integrin subunit (green; E9.5 and E11.5 are shown in figure 14). Surprisingly, αv is 
already detected in the myotomal myocytes at E9.5 (figure 14 B-D,) which is earlier than what 
had been reported before (Hirsch et al., 1994). It is present on all myocytes and is especially 
enriched at the tips (figure 14, arrows in B and D). The same distribution pattern is seen in all 
subsequent stages shown here at E11.5 on a longitudinal (figure 14 F-H, arrows in F and H) 
and on a transverse section (figures 14 J-L, arrows in J-L). Thus, αv integrin subunit seems to 
have a constant distribution pattern during myogenesis and it is restricted to differentiated, 
MHC-positive myogenic cells. It should be noted that we did not detect αv expression in the 
dermomyotome cells or in MPCs inside the myotome. 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: αv integrin subunit is especially enriched at the tips of epaxial myocytes. Cryosections of mouse 
embryos at stage E9.5, interlimb level (A-D, IL), E11.5 hindlimb level (E-H, HL) and E11.5 forelimb level (I-L, FL) at 
different orientations indicated in A, E and I. Sections were stained by immunohistochemistry for αv integrin subunit 
(green; B, F and J) and desmin and MHC (C) or just MHC (G and K). αv integrin subunit is expressed from early 
developmental stages (A-D) and enriched at the tips of myocytes (B and D, arrows). This expression pattern 
remains constant during the myogenic development, as αv integrin subunit is still mainly expressed on the tips of the 
epaxial myocytes (arrows in F, H, J and L). Embryo images were reproduced from 
http://mouseatlas.caltech.edu/gallery.html. NT-Neural tube; D-Dorsal; V-Ventral; M-Medial; L-Lateral; R-Rostral; C-
Caudal Scale bars: 100µm.  
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Functional study of the role of the fibronectin matrix assembly 
and cell-matrix interactions during myocyte translocation  
 
 Cultured embryo explants are viable and develop normally until 
12h of culture  
 Since the translocation of the myotome is characterized by extensive cellular 
reorganization, and because the receptors of fibronectin are present throughout these events 
(Cachaço et al 2005 and results shown above), we hypothesized that fibronectin could have a 
role during the morphogenesis of the epaxial muscles. Therefore, we aimed to assess how the 
attachment and interaction of the epaxial myocytes with the fibronectin matrix affects the 
myogenic cells during the translocation of the myotome. To answer this question we wanted to 
perturb the fibronectin assembly and the interaction of the cells with the fibronectin matrix in 
cultured explants.  
Our first major concern was to select the desired developmental stage to culture the 
explants and to assess whether the culture affects the morphology and the development of the 
explants. Ideally, the beginning of the culture would be when epaxial-most myocytes initiate the 
translocation phase and we should capture this translocation during the time of the culture. Two 
different stages were selected: E11.5 and E12.0 embryos. These embryos were cultured (figure 
7) for six or twelve hours to optimize the time of the culture. The control group called time zero 
(T0) was represented by the explants that were not cultured, but immediately fixed. For both 
developmental stages, immunohistochemistry were performed on whole mount explants which 
were stained with antibodies against MHC, fibronectin and TO-PRO3 for nuclear staining (table 
3) to see the morphology of the muscle masses and the ECM state.  
Explants from both E11.5 and E12.0 embryos have a normal morphology with no 
apparent abnormalities to report after 6h and 12h of culture (shown for E11.5 in figure 15), when 
compared with the T0 control embryos (figure 14A, B, E, F, I and J). In fact, in E11.5 explants 
cultured for 12h, epaxial myotomal myocytes are completely elongated from the intersegmental 
borders and they begin to form the characteristic tilt of the translocation process (figure 14, 
white arrow in I). This normal development of the myogenic cell masses indicates that the 
tissues are healthy and develop well. In accordance with this, the analysis of TO-PRO3 labeling 
did not reveal a big number of picnotic nuclei, characteristic of cell death (compare figures 15D, 
H and L).  
In parallel, the fibronectin matrix has a normal distribution pattern, as it is present 
around the whole segment, in the intersegmental borders, separating segments from each other 
(figure 15B, F and J) and among the muscle cells medially and laterally (figure 15, yellow arrows 
in C, G I and K). Moreover, the fibronectin matrix appears to keep its fibrillar conformation, at all 
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levels (figure 15A, E and I). Since we wanted a time of culture as long as possible to get as 
much as possible the translocation process during the culture, 12h was the time chosen to 
culture our experimental explants. 
However, the developmental time window of neither of these embryo stages was 
satisfying: E11.5 explants were too young with not enough translocation happening during the 
time of culture and E12.0 embryos were too old with already too many muscle fibres re-
orientated along the axis levels. Therefore, we chose to use an intermediate stage (E11.75) 
between the first two selected developmental stages to perform the experimental cultures. 
Table 6 summarizes the stage of development before and after culture of all the stages and 
time of cultured used in this study. 
 
Inhibition of fibronectin fibrillogenesis induces severe defects in 
skeletal muscle development  
Experiments were then performed on the chosen developmental stage E11.75 embryos 
cultured for 12h. As explained above, to see the culture effects,  the developmental changes 
through time and to ascertain their morphology before culture, we created a group of selected 
embryos that were not cultured (T0). Two sets of experiments were performed on the explants 
cultured for 12h. One set of explants was incubated with a 70KDa amino terminal fragment or 
BSA (a protein with the same molecular weight) to analyze the influence of fibronectin assembly 
on the development of the epaxial muscles during translocation of the myotome. The other set, 
was incubated with a peptide containing a RGD motif which blocks the binding of RGD-
containing integrins to fibronectin, or its control, the DGR peptide (figure 7). All the embryos and 
explants were stained by whole mount immunohistochemistry.  
Unexpectedly, all the explants cultured with the DGR peptide died during the cultures 
(n=9) Indeed after the culture the explants were opaque white and fragile characteristic of 
massive cell death instead of being translucide and elastic. This death could be due to an 
abnormal acidification of the medium as during the experiments, we noticed a change in the 
color of the culture medium (pink into orange) denoting an acidification of the medium. This 
medium acidification with GDR, which was also verified by other laboratory colleagues (Pedro 
Rifes, personal communication), was not observed in the other explant culture media. Another 
hypothesis to explain the acidification would be a contamination. Therefore, it was impossible to 
analyze these explants and the explants cultured with RGD do not have a specific control 
group. The RGE peptide would be more appropriate and will be incubated as control in future 
experiments (Danen et al., 2002). 
We first analyzed the muscle morphology of the explants by staining the myocytes using 
the anti-MHC antibody. First of all, it is important to note that the control cultured explants 
incubated with BSA (n=8) have a normal morphology (compare figures 15A and B with E and F 
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and 16A and B with E and F) and that they have developed normally compared to T0 control 
embryos (n=4).The dorsal-most myocytes of the T0 control embryos have changed their 
orientation and are no longer parallel to the embryo axis (figure16A and B, yellow arrow in A; 
17A and B).  In the explants cultured in BSA the complex structure of the epaxial muscle 
masses begins to stand out. In fact, it is now possible to identify the separation of the different 
muscle masses (figures 16E and F; 17E and F). Besides, when nuclei are analyzed, no massive 
cell death can be identified (compare figure 16D with H and 17D with H).  
Muscle masses of explants cultured with RGD (n=10) (figure 16 M-O; 17J-L) exhibit a 
normal phenotype through all levels and equal to the T0 control and BSA cultured explants. 
Again, myocytes are elongated through the whole segment, parallel to each other and the most 
epaxial ones have started to change orientation to give rise the adult muscle masses. Moreover, 
as in the control incubated with BSA, the separation between the different muscle masses 
becomes visible (figures 16M and N; 17M and N). This normal development is supported by a 
normal shape of the nuclei as well (figures 16P; 17P). 
The explants cultured with the 70KDa fragment (n=10) showed dramatic defects in the 
muscle mass morphology (figures 16I and J; 17I and J). When fibronectin fibrillogenesis is 
blocked, myocytes are shrunken and condensed. They also seem collapsed and misaligned on 
lateral and medial views, at all levels when compared to the control explants. However, the 
muscle masses did not exhibit massive cell death, as only few picnotic nuclei are present 
(figures15L; 16L). Interestingly, the ventral myocytes are more stretched and elongated than the 
dorsal ones, which could indicate that the fragment has a dorsal to ventral effect (figures 16, 
arrow in I; 17 arrows in G).  
 
 
 
 Figure 15 (next page): Morphological effect on explants development during culture. 3D 
reconstructions of interlimb level (A-C, E-G and I-K) of an E11.5 embryo fixed before culture (A-C;T0 
culture), embryo explants cultured for 6h (E-G; 6h culture) and for 12h (I-K; 12h culture) and optical sections 
stained with TO-PRO3 of each experimental group (D; T0 culture; H; 6h culture and L; 12h culture, 
respectively). Explants were immunostained for MHC (red) and fibronectin (green) The most anterior side of 
the explants is to the left in lateral views and to the right in the medial views. The epaxial (Ep) side is 
upwards and the hypaxial (Hyp) side downwards. Transversal (C, G and K) were also btained from 3D 
reconstructions. 6h and 12h cultured explants muscle masses developed normally with no apparent 
abnormities (A, B, D, E, F, H and white arrow in I). Fibronectin ECM is present in the intersegmental 
borders, ectoderm and surround the muscle masses (yellow arrows in C, G, I and K). D-Dorsal; V-Ventral; 
R-Rostral; C-Caudal. Scale bars: 150µm on whole mount reconstructions and 100µm on sections.  
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Inhibition of fibronectin assembly influences the tenascin matrix 
Previous studies showed that tenascin (TN), another component of the interstitial 
matrix, is present during muscle development. It colocalizes with fibronectin at the 
intersegmental borders and along the myotome and it is considered to be a tendon marker 
(Wang et al., 1995, Deries et al., 2011). In this study, we were interested to analyze the 
influence of fibronectin assembly and ECM - cell interactions via RGD on tenascin within the 
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developing tendons. To study this, explants whole mounts were stained with antibodies against 
TN matrix and MHC.  
Tenascin matrix had a similar normal phenotype at all levels of the control T0 explants 
(n=3; figure 16A-C) and explants incubated in BSA (n=6; figure 16E-G). Tenascin is strong at 
the intersegmental borders and bundles of tenascin run along the myocytes on the lateral and 
the medial side of the muscle masses (figure 16A, white arrow, B, arrows in C, E, F and arrows 
in G). Interestingly, explants muscle masses cultured with the 70KDa fragment (n=8) have 
completely lost their TN staining when compared with the T0 control embryos (figure 16I-J), 
suggesting that the disturbance of the fibronectin assembly perturbed the TN matrix. In contrast, 
TN matrix of the explants incubated with the RGD peptide (n=8) seemed to be normal, showing 
a similar phenotype as the T0 control. It is present at the intersegmental borders and between 
the muscle masses as well (figure 16M, N and arrows in O). Blocking the interaction of the cells 
with the matrix with the RGD peptide does not seem to have an effect on the TN matrix. 
 
Blocking fibronectin assembly cell-ECM interactions has a direct role 
on the myogenic differentiation program 
In order to study the influence of fibronectin assembly and interactions with the 
myogenic cells on the differentiation of the epaxial muscles, during translocation, we stained 
whole mount explants using antibodies against myogenin (table2, green; figure 17), to label the 
differentiating myogenic cells. T0 embryos have myogenin cells spread in the epaxial muscle 
masses and especially concentrated in the epaxial most part of the myotome. The differentiation 
program does not seem to be affected in explants cultured with BSA (n=2; figure 17D-F), when 
compared with the T0 control explants (n=1; figure 17A-C). Myogenin positive cells are seen, 
intermingled with the myocytes and more numerous at the epaxial most side (figure 17, arrows 
in C and F). Myogenin positive cells were absent in both explants cultured with the 70 kDa 
fragment (n=2; figure 17 G-I) and the RGD peptide (n=2; figure 17J-L). Therefore, we conclude 
that the perturbation of fibronectin fibrillognesis by 70kDa and blocking the interaction between 
cells and ECM with the RGD peptide pertubs the myogenic program. 
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Figure16: Inhibition of fibronectin assembly influences the intersticial ECM. 3D reconstructions of 
interlimb level of  E11.75 embryos fixed before culture (A-C;T0 culture), expants cultured 12h with BSA (E-G; 
12h BSA), explants cultured 12h with a 70KDa fragment (I-K; 12h 70KDa fragment) and explants culture 12h 
with the RGD peptide (M-O; 12h RGD). Optical sections show nuclei labelled with TO-PRO3 of each 
experimental group (D; T0 culture; H, 12h BSA; L; 12h 70KDa fragment and P; 12h RGD, respectively). 
Explants were immunostained with antibodies against MHC (red) and tenascin (green). The rostral side is to the 
left in lateral views and to the right in the medial views. The epaxial (Ep) side is upwards and the hypaxial (Hyp) 
side downwards. Transversal slabs (C, G, K and O) were obtained from 3D reconstructions. Explants cultured 
with BSA and RGD show a normal developed muscle masses morphology and tenascin labelling. The 
myocytes span from the borders and elongate and the most dorsal ones have started to change their orientation 
(arrow in A). Tenascin is strong at the intersegmental borders and bundles of tenascin run along the myocytes 
on the lateral and the medial side of the muscle masses (A, white arrow, B, C, arrows; E, F, G, arrows). In 
explants cultured with the 70KDa fragment, the myocytes are collapsed and this effect seems to be less severe 
on the most ventral side of the muscle masses (arrow in I). Tenascin matrix is not visible (I-K). D-Dorsal; V-
Ventral; R-Rostral; C-Caudal. Scale bars: 150µm on whole mount reconstructions and 100µm on sections.  
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Figure 17: Blocking fibronectin assembly cell-ECM interactions has a direct role on the 
myogenic differentiation program.  3D reconstructions of interlimb level of  E11.75 embryos 
fixed before culture (A-C; T0 culture), expants cultured 12h with BSA (E-G; 12h BSA), explants 
cultured 12h with a 70KDa fragment (I-K; 12h 70KDa fragment) and explants culture 12h with 
the RGD peptide (M-O; 12h RGD). Explants were immunostaining for MHC (red) and 
myogenin (green). The rostral side of the explants is to the left in lateral views and to the right 
in the medial views. The epaxial (Ep) side is upwards and the hypaxial (Hyp) side downwards. 
Transversal (C, G, K and O) were obtained from 3D reconstructions. Muscle masses 
developed normally in explants cultured with BSA and RGD (A, B, E, F, M and N). However, 
the explants incubated with the 70KDa exhibit shortened and collapsed (I-K) myocytes. This 
effect is not as strong on the ventral part of the muscle mass (arrows in I). Myogenin positive 
cells are seen in the T0 and BSA cultured explants (arrows in C and G).  However, both in 
70KDa and RGD cultured explants, no cells are positive for myogenin staining (I-K and M-O). 
Scale bars: 150µm on whole mount reconstructions and 50µm on sections.  
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Discussion  
 
Fibronectin matrix as a tendon-like structure 
We showed that at early stages, fibronectin is especially enriched in the intersegmental 
boundaries and all around the somites. These observations are in agreement with previous 
studies (Ostrovsky et al., 1988; Georges et al., 1993), which indicate that the epithelial somitic 
organization is dependent on the surrounding interstitial fibronectin matrix, as has been shown 
for the chick (Rifes et al., 2007; Martins et al., 2009). As the myotome forms, myocytes span the 
whole segment, elongate and penetrate into the fibronectin matrix at the intersegmental 
boundaries. Besides, fibronectin also spreads into the myotome from these intersegmental 
borders, suggesting multiple interactions between the matrix at intersegmental boundaries and 
muscle cells, but also indicating a constant adhesive and structural support, maintaining their 
morphology. In fact, it was proved in zebrafish that interactions between muscle fibers and 
fibronectin at somite boundaries mediate embryo segmentation (Henry et al., 2005). Moreover, 
zebrafish fibronectin mutants have disrupted myogenesis, due to disorganization and 
misalignment of myotomal cells (Snow et al., 2008). This suggests that fibronectin acts as a 
tendon-like structure. Our data support this hypothesis. In addition we have shown that the αv 
integrin subunit is detected on the tips of the myocytes, from early stages and remains 
especially enriched in the tips of the epaxial myocytes in the myotome during its development 
as well as during the morphogenesis of the epaxial muscle masses. Thus, αv integrin subunit, 
working in synchrony with α4β1 and α5β1 integrins which are also expressed in the myotome 
(Bajanca et al,2004; Cachaço et al., 2005) is in position to promote the anchoring of myotomal 
cells to the ECM. Taking this into account, we conclude that fibronectin is a prominent interstitial 
matrix, acting as a tendon-like structure, and possibly promoting the anchoring and consequent 
elongation of the differentiated myocytes.  
 
Fibronectin as a route for entry of MPCs into the myotome  
We also observed from early stages (being most clear at E10.5) that fibronectin matrix 
is present in the most lateral side of the mytome, i.e between the dermomyotome and myotome. 
Previously, we also showed that fibronectin matrix becomes denser inside the myotome. 
Interestingly, this developmental stage coincides with the beginning of the entry of MPCs from 
the central domain of the dermomyotme (Buckingham, 2006; Buckingham and Relaix, 2007; 
Relaix et al., 2005, Kassar-Duchossoy et al 2005). Furthermore, α4β1 integrin is known to be 
expressed in the dermomyotome (Bajanca et al., 2004) and, although it is not clear whether 
α5β1 in expressed on MPCs within the myotome, it is expressed by migrating limb MPCs 
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(Bajanca and Thorsteinsdóttir, 2002). In fact, we see that myotomal MPCs have close 
relationship with the fibronectin matrix. To clarify this issue further, it would be interesting extend 
this study to include a tridimensional approach, in which the spatial relationships between the 
MPCs and the fibronectin matrix is easier to analyze.   
At approximately at E11.5 in the mouse, the dermomyotome begins to de-epithelialise 
and eventually disappears and at the same time, we recorded a massive invasion of fibronectin 
matrix into the dermomyotome space. In parallel, the number of the fibronectin fibrils increases 
as the muscle masses reach their full maturation, and, globally, the fibronectin matrix complexity 
increases as well. It is possible that fibronectin palys a role in guiding the MPC population, 
which is released upon the dissociation of the myotome, into the myotome at this stage as well. 
We suggest that Pax3/Pax7 positive cells use the fibronectin matrix to enter into the myotome, 
where they then proliferate and/or eventually differentiate. Fibronectin may act as a guiding cue, 
providing mechanical, physical or even a chemical extracellular environment (a particular micro-
niche), in which MPCs can orient themselves, via an ECM-mediated mechanism.  
 
An intact fibronectin matrix is essential for normal myocyte 
morphology, tenascin matrix accumulation and myocyte 
translocation. 
At the stage of experimental cultures, the myotomal myocytes change their orientation 
and translocate to the final maturation location to give rise the adult epaxial musculature (Deries 
et al., 2010). Furthermore, the number of fibronectin fibrils increases. When the muscle masses 
start to translocate, fibronectin continues to be detected around and within of those muscle 
masses. Taking all these results into account, fibronectin seems to be the primary candidate to 
promote reorientation of myogenic cells during the translocation phase, and possibly also their 
fusion, thus being a candidate regulator of skeletal muscle morphogenesis. 
  We used an amino terminal 70kDa fragment to inhibit the fibronectin assembly 
(McKeown-Longo and Mosher, 1985). When fibronectin assembly is blocked, myocyte 
morphology is severely affected, especially in the most epaxial domain. Indeed, muscle cells 
were collapsed and shrunken. This cell morphology could suggest cell death. However, the 
nuclear shape of the cells within the tissues apparently seemed normal, without an abnormally 
high number of picnotic nucleus, which suggests that the disruption of fibronectin assembly and 
its consequences do not induce cell death. However, the picnotic phenotype appears at the last 
stage of apoptosis when the nucleus condenses and get fragmented (Kroemer et al., 2009). 
Therefore, it is possible that myogenic cells have entered apoptosis but have not advanced 
enough to show picnotic nuclei. If that was the case, it would show that fibronectin has a role in 
the survival of myogenic cells. To verify this possibility, it would be interesting to stain the cells 
by immunohistochemistry with an antibody against caspase3, a protein that has been shown to 
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be involved in the early steps of apoptosis. The absence of tenascin matrix in these explants 
was constant at all levels. It is known in cancer that tenascin needs fibronectin to be able to 
assemble (Jones and Jones, 2000), Moreover, in the early embryo, fibronectin is present before 
tenascin (Crossin et al, 1986; Ostrovsky et al.,1988). In these experiments, fibronectin 
fibrillogenesis was completely inhibited and it apparently leads to the complete disappearance 
of tenascin. The dramatic phenotype of the myocytes, being shortened may be explained by the 
fact that the muscle cells no longer have the support of fibronectin nor tenascin.  
The data obtained highlights the importance of the fibronectin as a major and crucial component 
of the interstitial matrix, which constitutes an adhesive substrate for the support, elongation and 
translocation of myocytes within the muscle masses. 
 
Blocking cell-ECM interactions through the RGD motif does not 
perturb myocyte morphology, tenascin matrix formation or 
myocyte translocation. 
The RGD peptide blocks the binding of RGD-containing integrins to fibronectin, in 
particular the α5β1 and αv-containing integrins (Takahashi et al., 2007). Muscle of explants 
cultures incubated with RGD exhibit a normal morphology. This could indicate that the 
interaction between cells and fibronectin via RGD motif is not essential for the morphology of 
the epaxial muscles during their development. However, it could also mean that the interaction 
of other integrins with fibronectin, such as the α4β1 integrin, which is a non-RGD-dependent  
fibronectin receptor (Sechler et al., 2000) and expressed during the stage under study (Cachaço 
et al 2005), is sufficient to support the myotcytes when interaction through the RGD motif is 
impaired. It is also possible that other ECM molecules, for example collagens (Thorsteindóttir et 
al., 2011), act in concert with fibronectin and compensate the interactive interruption between 
cells and the fibronectin and tenascin matrices. To test this hypothesis, additional studies, 
where the interactions between α4β1 integrin and fibronectin are specifically inhibited, could be 
conducted. 
 
An intact fibronectin matrix and cell-ECM interactions through 
RGD are essential for the entry of MPCs into the myogenic 
programme. 
Surprisingly, myogenin labeling is completely absent in explants incubated with the 
70kDa fragment showing that the differentiation program was affected. These results suggest 
that the assembly of fibronectin could have an effect upon the expression of myogenin. Several 
explanations could be drawn to explain the fibronectin functions in myogenesis. The use of the 
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70kDa fragment prevents fibronectin fibrillogenesis. Thus the state of the fibronectin marix could 
influence the cellular fate.  Interestingly, explants cultured with the RGD peptide exhibit the 
same phenotype as the explants incubated with the fragment. These results suggest that during 
muscle development MPCs within the muscle masses need to be in permanent contact with the 
fibronectin matrix through the RGD motif to proceed in their differentiation programme. Inhibiting 
these interactions may have caused the cells to block the myogenic gene expression, such as 
myogenin, This interesting hypothesis implies that the interaction of myogenic cells with the 
ECM through the RGD motif would have outside-in signaling role (Hynes, 2002) on the 
myogenic program. If this hypothesis is correct, cell-ECM binding through RGD may target 
integrin signaling to the nucleus.  
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Conclusion 
 
In summary, the data presented in this thesis highlights that fibronectin matrix is a very 
dynamic matrix in vivo, and could be a key molecule in the regulation of myogenic development, 
by instructing different morphogenetic cellular behaviors. During embryogenesis, the ECM is 
consistently being remodeled, adjusting itself as the embryo proceeds in its intrinsic 
development. In this study, we highlighted that the nature and architecture of fibronectin matrix 
directly affects and are related with characteristic phenomena of muscle differentiation and that 
interferes with the muscle masses organization. Knowing that the fibronectin matrix assembly is 
a cellular event (Mao and Schwarzbauer, 2005) it means that cells create their own extracellular 
environment, which is later necessary for their development, thus influencing their own fate. 
Therefore, studying the architecture of ECM components, the cell-ECM adhesive properties 
help to understand the ECM dimension not only for skeletal muscle development, but may also 
provide useful knowledge on other important morphogenetic events.  
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Annex I 
 
Recipes 
 
10x Phosphate Buffer Saline (PBS) – 1370 mM NaCl 
                                                                    268 mM KCl 
                                                                    81 mM Na2HPO4.H2O 
                                                                   147 mM KH2PO4 
                                                                                                        Fill with distilled water 
 
20% Paraformaldehyde (PFA) – 200 g PFA 
                                                               Fill with distilled water (1L) 
 
 
Sucrose Solutions for cryosectioning  
  
 Solution 1 – 40 g sucrose 
                                                    120 µl CaCl2 (dissolve in water first) 
                                                     385 ml Na2HPO4 
                                                     115 ml NaH2PO4 
                                                     Fill with distilled water (1L) 
 
 Solution 2 – 150 g sucrose 
                                                     5 ml Phosphate Buffer 1 
                                                     Fill with distilled water (1L) 
 
 Solution 3 – 150 g sucrose 
                                                     75 g gelatin 
                                                     500 ml Phosphate Buffer 2 
 
 
    0.2% ID – 0.2% Triton (v/v) 
                  1% BSA (v/v) 
                  Fulfill with PBS 
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Blocking Solution – 1% BSA (v/v)  
                                    20% DMSO (v/v) 
                                    75% PBS (v/v) 
 
 
HEPES (1M) – 11.915g HEPES 
                         50 ml destilled water 
 
 
Propyl-galate-PBS-Glycerol – 4% N-Propyl-galate (v/v) 
                                                     90% Glycerol (v/v) 
                                                     10% 10x PBS (v/v) 
                                                 
 
 
 
 
 
 
 
 
 
 
 
